Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more

NPCE Insider Trading (NeuroPace)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $4,884,984.00
Insider Selling (Last 12 Months): $0.00

NeuroPace Insider Trading History Chart

This chart shows the insider buying and selling history at NeuroPace by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NeuroPace Share Price & Price History

Current Price: $16.91
Price Change: Price Decrease of -0.55 (-3.15%)
As of 09/27/2021 01:00 AM ET

This chart shows the closing price history over time for NPCE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
717% Since May 2019?!
Members had the chance to more than 10X their TOTAL PORTFOLIOS by following our recommendations since May 2019...

That's why for one week you can join us as we analyze the market LIVE...

And get all our market intelligence and real-time trading recommendations...

Just RSVP Here (No Cost, No Obligation).
Learn more.
pixel

NeuroPace Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/21/2021Frank M FischerDirectorBuy50,000$17.00$850,000.0093,291View SEC Filing Icon  
4/21/2021Irina RidleyGeneral CounselBuy2,352$17.00$39,984.002,352View SEC Filing Icon  
4/21/2021Orbimed Advisors LlcMajor ShareholderBuy235,000$17.00$3,995,000.00588,235View SEC Filing Icon  
See Full Table
Insider Trading at NeuroPace?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for NeuroPace and related companies.

SEC Filings (Institutional Ownership Changes) for NeuroPace (NASDAQ:NPCE)

44.60% of NeuroPace stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NPCE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

NeuroPace Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/25/2021Marshall Wace LLP14,939$0.36M0.0%N/A0.061%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley7,592$0.18M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN10,221$0.24M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC254,238$6.05M0.0%N/A1.047%Search for SEC Filing on Google Icon
8/17/2021Caas Capital Management LP40,000$0.95M0.0%N/A0.165%Search for SEC Filing on Google Icon
8/16/2021Bank of America Corp DE2,037$48K0.0%N/A0.008%Search for SEC Filing on Google Icon
8/16/2021Nantahala Capital Management LLC147,404$3.51M0.1%N/A0.607%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System9,587$0.23M0.0%N/A0.039%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley7,592$0.18M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.17,448$0.42M0.0%N/A0.072%Search for SEC Filing on Google Icon
8/16/2021State Street Corp72,806$1.73M0.0%N/A0.300%Search for SEC Filing on Google Icon
8/16/2021Nuveen Asset Management LLC11,008$0.26M0.0%N/A0.045%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp71,277$1.70M0.0%N/A0.293%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC110,980$2.64M0.0%N/A0.457%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.291,976$6.95M0.0%N/A1.202%Search for SEC Filing on Google Icon
8/13/2021FMR LLC1,060,059$25.22M0.0%N/A4.364%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.7,993$0.19M0.0%N/A0.033%Search for SEC Filing on Google Icon
8/12/2021Bellevue Group AG507,930$12.08M0.1%N/A2.091%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp11,499$0.27M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.334,495$7.96M0.0%N/A1.377%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,133$98K0.0%N/A0.017%Search for SEC Filing on Google Icon
8/11/2021Lord Abbett & CO. LLC247,368$5.89M0.0%N/A1.018%Search for SEC Filing on Google Icon
8/5/2021American Century Companies Inc.402,754$9.58M0.0%N/A1.658%Search for SEC Filing on Google Icon
8/3/2021Johnson & Johnson Innovation JJDC Inc.55,435$1.32M0.1%N/A0.228%Search for SEC Filing on Google Icon
8/2/2021New York State Common Retirement Fund6,000$0.14M0.0%N/A0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
NeuroPace logo
NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Read More on NeuroPace

Today's Range

Now: $16.91
Low: $16.68
High: $17.76

50 Day Range

MA: $20.82
Low: $16.39
High: $24.30

52 Week Range

Now: $16.91
Low: $16.20
High: $27.38

Volume

21,656 shs

Average Volume

103,507 shs

Market Capitalization

$410.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of NeuroPace?

NeuroPace's top insider investors include:
  1. Orbimed Advisors Llc (Major Shareholder)
  2. Frank M Fischer (Director)
  3. Irina Ridley (General Counsel)

Who are the major institutional investors of NeuroPace?

NeuroPace's top institutional shareholders include:
  1. FMR LLC — 4.36%
  2. Bellevue Group AG — 2.09%
  3. American Century Companies Inc. — 1.66%
  4. BlackRock Inc. — 1.38%
  5. Vanguard Group Inc. — 1.20%
  6. Millennium Management LLC — 1.05%

Which institutional investors are buying NeuroPace stock?

In the previous quarter, NPCE stock was bought by institutional investors including:
  1. FMR LLC
  2. Bellevue Group AG
  3. American Century Companies Inc.
  4. BlackRock Inc.
  5. Vanguard Group Inc.
  6. Millennium Management LLC
  7. Lord Abbett & CO. LLC
  8. Nantahala Capital Management LLC
Within the previous year, these company insiders have bought NeuroPace stock:
  1. Orbimed Advisors Llc (Major Shareholder)
  2. Frank M Fischer (Director)
  3. Irina Ridley (General Counsel)
Hottest Stock Pick for 2021
This could be the most underrated stock available. Watch it closely.
Click here to learn more